Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2

J Antibiot (Tokyo). 2013 Sep;66(9):543-8. doi: 10.1038/ja.2013.42. Epub 2013 May 1.

Abstract

Because stromal cells can regulate the growth and metastasis of tumor cells, a compound that modulates the interaction between the stromal cells and the tumor cells can control the tumor progression. In the course of our screening for such a compound, we have isolated a new compound, intervenolin, from the culture broth of Nocardia sp. ML96-86F2. Intervenolin inhibits the growth of human gastric and colorectal cancer cell lines in the coculture with the respective organ-derived stromal cells more strongly than that of the cancer cells cultured alone. Intervenolin shows antitumor effect against a xenograft model of human colorectal cancer cells in vivo. Furthermore, intervenolin exerts selective anti-Helicobacter pylori effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / pharmacology*
  • Antibiotics, Antineoplastic / isolation & purification
  • Antibiotics, Antineoplastic / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Coculture Techniques
  • Colorectal Neoplasms / drug therapy
  • Disease Models, Animal
  • Female
  • Helicobacter pylori / drug effects*
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred ICR
  • Microbial Sensitivity Tests
  • Nocardia / chemistry*
  • Quinolones / isolation & purification
  • Quinolones / pharmacology*
  • Stromal Cells / drug effects

Substances

  • Anti-Bacterial Agents
  • Antibiotics, Antineoplastic
  • Quinolones
  • intervenolin